Trial Profile
A Randomized, Single-blind, Placebo-controlled, Multicentre Study to Evaluate the Effect of Risedronate and Placebo on Bone Mineral Density in Men Undergoing Androgen Deprivation Therapy With Leuprolide Acetate
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Osteoporosis; Prostate cancer
- Focus Therapeutic Use
- 07 Feb 2012 New trial record